A Study of GR1803 in Systemic Lupus Erythematosus

Clinical trial NCT07348055 · RECRUITING

Trial details

NCT number: NCT07348055
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erthematosus Auto Immune Disease

Start date: 2026-02-02
Primary completion: 2027-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.